What’s New? - Preliminary Data Demonstrates KIO-301 Restored Visual Function in Retinitis Pigmentosa Study.

Our vision: healthy and functional eyes

Bringing innovative ophthalmic therapies to market

Find out more about our therapies

Kiora Pharmaceuticals, Inc. (Kiora) is an ophthalmic specialty pharmaceutical company that develops therapies for the treatment of different types of eye diseases. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision.

Learn more about our company
In the Pipeline
Loading RSS Feed